Report cover image

Global Anti-counterfeiting Pharmaceutical Packaging Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 194 Pages
SKU # APRC20559124

Description

Summary

According to APO Research, the global Anti-counterfeiting Pharmaceutical Packaging market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Anti-counterfeiting Pharmaceutical Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Anti-counterfeiting Pharmaceutical Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Anti-counterfeiting Pharmaceutical Packaging market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Anti-counterfeiting Pharmaceutical Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Anti-counterfeiting Pharmaceutical Packaging market include Amcor PIc, Ball Corp., Becton Dickinson and Co., Berry Global Group Inc., Catalent Inc., Gerresheimer AG, O-I Glass Inc.SCHOTTAG, West Pharmaceutical Services Inc. and WestRock Co., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-counterfeiting Pharmaceutical Packaging, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Anti-counterfeiting Pharmaceutical Packaging, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-counterfeiting Pharmaceutical Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-counterfeiting Pharmaceutical Packaging sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Anti-counterfeiting Pharmaceutical Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Anti-counterfeiting Pharmaceutical Packaging sales, projected growth trends, production technology, application and end-user industry.

Anti-counterfeiting Pharmaceutical Packaging Segment by Company

Amcor PIc
Ball Corp.
Becton Dickinson and Co.
Berry Global Group Inc.
Catalent Inc.
Gerresheimer AG
O-I Glass Inc.SCHOTTAG
West Pharmaceutical Services Inc.
WestRock Co.
Anti-counterfeiting Pharmaceutical Packaging Segment by Type

Plastic Film
Aluminum Foil
Glass
Anti-counterfeiting Pharmaceutical Packaging Segment by Application

Medicine
Nutraceuticals
Others
Anti-counterfeiting Pharmaceutical Packaging Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Anti-counterfeiting Pharmaceutical Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Anti-counterfeiting Pharmaceutical Packaging market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Anti-counterfeiting Pharmaceutical Packaging significant trends, drivers, influence factors in global and regions.
6. To analyze Anti-counterfeiting Pharmaceutical Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-counterfeiting Pharmaceutical Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-counterfeiting Pharmaceutical Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-counterfeiting Pharmaceutical Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-counterfeiting Pharmaceutical Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-counterfeiting Pharmaceutical Packaging industry.
Chapter 3: Detailed analysis of Anti-counterfeiting Pharmaceutical Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Anti-counterfeiting Pharmaceutical Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Anti-counterfeiting Pharmaceutical Packaging in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value (2020-2031)
1.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume (2020-2031)
1.2.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Anti-counterfeiting Pharmaceutical Packaging Market Dynamics
2.1 Anti-counterfeiting Pharmaceutical Packaging Industry Trends
2.2 Anti-counterfeiting Pharmaceutical Packaging Industry Drivers
2.3 Anti-counterfeiting Pharmaceutical Packaging Industry Opportunities and Challenges
2.4 Anti-counterfeiting Pharmaceutical Packaging Industry Restraints
3 Anti-counterfeiting Pharmaceutical Packaging Market by Company
3.1 Global Anti-counterfeiting Pharmaceutical Packaging Company Revenue Ranking in 2024
3.2 Global Anti-counterfeiting Pharmaceutical Packaging Revenue by Company (2020-2025)
3.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Company (2020-2025)
3.4 Global Anti-counterfeiting Pharmaceutical Packaging Average Price by Company (2020-2025)
3.5 Global Anti-counterfeiting Pharmaceutical Packaging Company Ranking (2023-2025)
3.6 Global Anti-counterfeiting Pharmaceutical Packaging Company Manufacturing Base and Headquarters
3.7 Global Anti-counterfeiting Pharmaceutical Packaging Company Product Type and Application
3.8 Global Anti-counterfeiting Pharmaceutical Packaging Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Anti-counterfeiting Pharmaceutical Packaging Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Anti-counterfeiting Pharmaceutical Packaging Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Anti-counterfeiting Pharmaceutical Packaging Market by Type
4.1 Anti-counterfeiting Pharmaceutical Packaging Type Introduction
4.1.1 Plastic Film
4.1.2 Aluminum Foil
4.1.3 Glass
4.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type
4.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Type (2020-2031)
4.2.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Type (2020-2031)
4.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type
4.3.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Type (2020-2031)
4.3.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type (2020-2031)
5 Anti-counterfeiting Pharmaceutical Packaging Market by Application
5.1 Anti-counterfeiting Pharmaceutical Packaging Application Introduction
5.1.1 Medicine
5.1.2 Nutraceuticals
5.1.3 Others
5.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application
5.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume by Application (2020-2031)
5.2.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Volume Share by Application (2020-2031)
5.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application
5.3.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Application (2020-2031)
5.3.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application (2020-2031)
6 Anti-counterfeiting Pharmaceutical Packaging Regional Sales and Value Analysis
6.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region (2020-2031)
6.2.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region: 2020-2025
6.2.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Region (2026-2031)
6.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region (2020-2031)
6.4.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region: 2020-2025
6.4.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Region (2026-2031)
6.5 Global Anti-counterfeiting Pharmaceutical Packaging Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Anti-counterfeiting Pharmaceutical Packaging Sales Value (2020-2031)
6.6.2 North America Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Anti-counterfeiting Pharmaceutical Packaging Sales Value (2020-2031)
6.7.2 Europe Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Anti-counterfeiting Pharmaceutical Packaging Sales Value (2020-2031)
6.8.2 Asia-Pacific Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Anti-counterfeiting Pharmaceutical Packaging Sales Value (2020-2031)
6.9.2 South America Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Anti-counterfeiting Pharmaceutical Packaging Sales Value (2020-2031)
6.10.2 Middle East & Africa Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Country, 2024 VS 2031
7 Anti-counterfeiting Pharmaceutical Packaging Country-level Sales and Value Analysis
7.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2020-2031)
7.3.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2020-2025)
7.3.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales by Country (2026-2031)
7.4 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2020-2031)
7.4.1 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2020-2025)
7.4.2 Global Anti-counterfeiting Pharmaceutical Packaging Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.5.2 USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.6.2 Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.8.2 Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.9.2 France Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.9.3 France Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.11.2 Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.12.2 Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.13.2 Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.16.2 China Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.16.3 China Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.17.2 Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.19.2 India Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.19.3 India Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.20.2 Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.24.2 Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.26.2 Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.28.2 Israel Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.29.2 UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.31.2 Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Anti-counterfeiting Pharmaceutical Packaging Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Amcor PIc
8.1.1 Amcor PIc Comapny Information
8.1.2 Amcor PIc Business Overview
8.1.3 Amcor PIc Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.1.4 Amcor PIc Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.1.5 Amcor PIc Recent Developments
8.2 Ball Corp.
8.2.1 Ball Corp. Comapny Information
8.2.2 Ball Corp. Business Overview
8.2.3 Ball Corp. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.2.4 Ball Corp. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.2.5 Ball Corp. Recent Developments
8.3 Becton Dickinson and Co.
8.3.1 Becton Dickinson and Co. Comapny Information
8.3.2 Becton Dickinson and Co. Business Overview
8.3.3 Becton Dickinson and Co. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.3.4 Becton Dickinson and Co. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.3.5 Becton Dickinson and Co. Recent Developments
8.4 Berry Global Group Inc.
8.4.1 Berry Global Group Inc. Comapny Information
8.4.2 Berry Global Group Inc. Business Overview
8.4.3 Berry Global Group Inc. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.4.4 Berry Global Group Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.4.5 Berry Global Group Inc. Recent Developments
8.5 Catalent Inc.
8.5.1 Catalent Inc. Comapny Information
8.5.2 Catalent Inc. Business Overview
8.5.3 Catalent Inc. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.5.4 Catalent Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.5.5 Catalent Inc. Recent Developments
8.6 Gerresheimer AG
8.6.1 Gerresheimer AG Comapny Information
8.6.2 Gerresheimer AG Business Overview
8.6.3 Gerresheimer AG Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.6.4 Gerresheimer AG Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.6.5 Gerresheimer AG Recent Developments
8.7 O-I Glass Inc.SCHOTTAG
8.7.1 O-I Glass Inc.SCHOTTAG Comapny Information
8.7.2 O-I Glass Inc.SCHOTTAG Business Overview
8.7.3 O-I Glass Inc.SCHOTTAG Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.7.4 O-I Glass Inc.SCHOTTAG Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.7.5 O-I Glass Inc.SCHOTTAG Recent Developments
8.8 West Pharmaceutical Services Inc.
8.8.1 West Pharmaceutical Services Inc. Comapny Information
8.8.2 West Pharmaceutical Services Inc. Business Overview
8.8.3 West Pharmaceutical Services Inc. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.8.4 West Pharmaceutical Services Inc. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.8.5 West Pharmaceutical Services Inc. Recent Developments
8.9 WestRock Co.
8.9.1 WestRock Co. Comapny Information
8.9.2 WestRock Co. Business Overview
8.9.3 WestRock Co. Anti-counterfeiting Pharmaceutical Packaging Sales, Value and Gross Margin (2020-2025)
8.9.4 WestRock Co. Anti-counterfeiting Pharmaceutical Packaging Product Portfolio
8.9.5 WestRock Co. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Anti-counterfeiting Pharmaceutical Packaging Value Chain Analysis
9.1.1 Anti-counterfeiting Pharmaceutical Packaging Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Anti-counterfeiting Pharmaceutical Packaging Sales Mode & Process
9.2 Anti-counterfeiting Pharmaceutical Packaging Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Anti-counterfeiting Pharmaceutical Packaging Distributors
9.2.3 Anti-counterfeiting Pharmaceutical Packaging Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.